Literature DB >> 25413673

Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia.

Maro Ohanian1, Uri Rozovski, Farhad Ravandi, Guillermo Garcia-Manero, Elias Jabbour, Hagop M Kantarjian, Zeev Estrov.   

Abstract

Entities:  

Keywords:  acute promyelocytic leukaemia; central nervous system; lactate dehydrogenase

Mesh：

Substances：

Year:  2014        PMID： 25413673      PMCID： PMC4414662          DOI： 10.1111/bjh.13230

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.

Authors:  Lionel Adès; Sylvie Chevret; Emmanuel Raffoux; Stephane de Botton; Agnes Guerci; Arnaud Pigneux; Anne Marie Stoppa; Thierry Lamy; Francoise Rigal-Huguet; Anne Vekhoff; Sandrine Meyer-Monard; Frederic Maloisel; Eric Deconinck; Augustin Ferrant; Xavier Thomas; Nathalie Fegueux; Christine Chomienne; Herve Dombret; Laurent Degos; Pierre Fenaux
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

2.  Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

Authors:  S de Botton; M A Sanz; S Chevret; H Dombret; G Martin; X Thomas; J D Mediavilla; C Recher; L Ades; B Quesnel; P Brault; M Fey; H Wandt; D Machover; A Guerci; F Maloisel; A M Stoppa; C Rayon; J M Ribera; C Chomienne; L Degos; P Fenaux
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

3.  Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.

Authors:  K Irani; Y Xia; J L Zweier; S J Sollott; C J Der; E R Fearon; M Sundaresan; T Finkel; P J Goldschmidt-Clermont
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

Review 4.  Treatment of relapsed or refractory acute promyelocytic leukemia.

Authors:  Martin S Tallman
Journal:  Best Pract Res Clin Haematol       Date:  2007-03       Impact factor: 3.020

5.  Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia--the occurrence of retinoic acid syndrome is a risk factor.

Authors:  B S Ko; J L Tang; Y C Chen; M Yao; C H Wang; M C Shen; H F Tien
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

6.  Hypoxia is important in the biology and aggression of human glial brain tumors.

Authors:  Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

7.  Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.

Authors:  Pau Montesinos; Joaquín Díaz-Mediavilla; Guillermo Debén; Virginia Prates; Mar Tormo; Vicente Rubio; Inmaculada Pérez; Isolda Fernández; Maricruz Viguria; Chelo Rayón; José González; Javier de la Serna; Jordi Esteve; Juan M Bergua; Concha Rivas; Marcos González; Jose D González; Silvia Negri; Salut Brunet; Bob Lowenberg; Miguel A Sanz
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

8.  Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Authors:  Miguel A Sanz; Guillermo Martín; Marcos González; Angel León; Chelo Rayón; Concha Rivas; Dolors Colomer; Elena Amutio; Francisco J Capote; Gustavo A Milone; Javier De La Serna; José Román; Eva Barragán; Juan Bergua; Lourdes Escoda; Ricardo Parody; Silvia Negri; María J Calasanz; Pascual Bolufer
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

9.  Plasma and intracellular levels of lactate dehydrogenase, phosphohexose isomerase and lysozyme activity in acute leukemia.

Authors:  A D Ho; W Fiehn; W Hunstein
Journal:  Blut       Date:  1984-07

10.  The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.

Authors:  J Cortes; S M O'Brien; S Pierce; M J Keating; E J Freireich; H M Kantarjian
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113
  10 in total
  2 in total

Review 1.  Isolated Central Nervous System (CNS) Relapse in Paediatric Acute Promyelocytic Leukaemia: A Systematic Review.

Authors:  Smeeta Gajendra; Rashmi Ranjan Das; Rashi Sharma
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study.

Authors:  Wanzi Chen; Hangmin Liu; Pengcheng Wang; Guoping Li
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.